Transpacific TAVR Registry
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age19+
SponsorDuk-Woo Park, MD
About this trial
This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.
Eligibility criteria
Qualifiers
All patients undergoing TAVR
Informed consent
Disqualifiers
None
Trial design
Treatments tested in this trial
- TAVR
Treatment groups
10,000 Participants
are divided into 4 treatment groupsLocations
7China
Second Affiliated Hospital of Zhejiang University Hangzhou China
South Korea
Bucheon Sejong Hospital Bucheon-si South Korea
Chungnam National University Hospital Daejeon South Korea
Asan Medical Center Seoul South Korea
Sponsors and collaborators
Duk-Woo Park, MD
Lead sponsor
Asan Medical Center
Sponsor institution
CardioVascular Research Foundation, Korea
Collaborator
Source ClinicalTrials.gov